Journal of Surgery Concepts & Practice >

2021 , Vol. 26 >Issue 06: 517 - 521

DOI: https://doi.org/10.16139/j.1007-9610.2021.06.012

Original article

Preoperative evaluation and preparation of Graves′ disease: a report of 126 cases

Expand
  • Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2021-11-08

  Online published: 2022-07-27

Fold

Abstract

Objective To analyze retrospectively preoperative evaluation and preparation in Graves′ disease patients with surgical treatment. Methods A total of 126 cases of Graves′ disease in our department from January 2015 to May 2021 were reviewed. Patient information including preoperative preparation, operative mode, postoperative pathological results and complications were collected. Results There were 27 males and 99 females with an average age of(42.4±14.3) years. Surgical indications were Graves′ disease with malignant tumour, airway compression and stenosis, retrosternal goiter, drug intolerance or hyperparathyroidism. There were 75 cases with thyroid papillary carcinoma including 47 cases with papillary microcarcinoma， and 2 cases with follicular carcinoma. Short-term postoperative complications were 11 cases with hoarseness among which 1 case was permanent, and 35 cases with hypocalcemia among which 1 case was permanent. Conclusions It is indicated that preoperative preparation for Graves′ disease requires individualization and refinement, which include iodine preparation, examination of airway condition and neural monitoring, the evaluation of parathyroid function, recurrent laryngeal nerve variation and malignant nodules.

Key words： Graves′ disease; Thyroidectomy; Preoperative preparation; Complication

Cite this article

SUN Hanxing, SHEN Xiaohui, GAO Haoji, LIU Zhuoran, CHEN Xi, QIU Weihua, YAN Jiqi . Preoperative evaluation and preparation of Graves′ disease: a report of 126 cases[J]. Journal of Surgery Concepts & Practice, 2021 , 26(06) : 517 -521 . DOI: 10.16139/j.1007-9610.2021.06.012

References

[1] Davies TF, Andersen S, Latif R, et al. Graves′ disease[J]. Nat Rev Dis Primers, 2020, 6(1):52.
[2] 中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会, 中国医疗保健国际交流促进会临床实用技术分会. 甲状腺功能亢进症外科治疗中国专家共识(2020版)[J]. 中国实用外科杂志, 2020, 40(11):1229-1233.
[3] Rubio GA, Koru-Sengul T, Vaghaiwalla TM, et al. Postoperative outcomes in Graves′ disease patients: results from the nationwide inpatient sample database[J]. Thyroid, 2017, 27(6):825-831.
[4] Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J]. Thyroid, 2016, 26(10):1343-1421.
[5] Randle RW, Bates MF, Long KL, et al. Impact of potas-sium iodide on thyroidectomy for Graves′ disease: implications for safety and operative difficulty[J]. Surgery, 2018, 163(1):68-72.
[6] Lindner K, Kuβmann J, Fendrich V. Preoperative potassium iodide treatment in patients undergoing thyroidectomy for Graves′ disease-perspective of a European high-volume center[J]. World J Surg, 2020, 44(10):3405-3409.
[7] 中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺及甲状旁腺手术中神经电生理监测临床指南(中国版)[J]. 中国实用外科杂志, 2013, 33(6):470-474.
[8] 邵堂雷, 杨卫平, 王海, 等. 甲状腺外科手术中喉不返神经的解剖研究[J]. 中华普通外科杂志, 2009, 24(12):963-965.
[9] Iacobone M, Citton M, Pagura G, et al. Increased and safer detection of nonrecurrent inferior laryngeal nerve after preoperative ultrasonography[J]. Laryngoscope, 2015, 125(7):1743-1747.
[10] Watanabe A, Taniguchi M, Kimura Y, et al. Efficient, effective, safe procedure to identify nonrecurrent inferior laryngeal nerve during thyroid surgery[J]. Head Neck, 2016, 38(4):573-577.
[11] 孙辉, 刘晓莉, 赵涛, 等. 术中神经监测识别非返性喉返神经6例经验[J]. 中华内分泌外科杂志, 2010, 4(6):402-404.
[12] Kazaure HS, Zambeli-Ljepovic A, Oyekunle T, et al. Severe hypocalcemia after thyroidectomy: an analysis of 7366 patients[J]. Ann Surg,2019-12-05[online ahead of print].
[13] Giovanella L, Suriano S, Ceriani L. Graves′ disease, thymus enlargement, and hypercalcemia[J]. N Engl J Med, 2008, 358(10):1078-1079.
[14] Wei S, Baloch ZW, LiVolsi VA. Parathyroid adenoma in patients with Graves′ disease: a report of 21 cases[J]. Endocr Pathol, 2015, 26(1):71-74.
[15] Staniforth JUL, Erdirimanne S, Eslick GD. Thyroid carcinoma in Graves′ disease: a meta-analysis[J]. Int J Surg, 2016, 27:118-125.
[16] Wei S, Baloch ZW, LiVolsi VA. Thyroid carcinoma in patients with Graves′ disease: an institutional experience[J]. Endocr Pathol, 2015, 26(1):48-53.
[17] Mekraksakit P, Rattanawong P, Karnchanasorn R, et al. Prognosis of differentiated thyroid carcinoma in patients with Graves disease: a systematic review and meta-analysis[J]. Endocr Pract, 2019, 25(12):1323-1337.
[18] Song Y, Fu L, Wang P, et al. Effect of Graves′disease on the prognosis of differentiated thyroid carcinoma: a meta-analysis[J]. Endocrine, 2020, 67(3):516-525.
[19] 黄海燕, 匡洁, 应夏洋, 等. Graves病合并甲状腺癌(附47例报告)[J]. 外科理论与实践, 2018, 23(6):519-522.
[20] Kwon H, Moon BI. Prognosis of papillary thyroid cancer in patients with Graves′ disease: a propensity score-matched analysis[J]. World J Surg Oncol, 2020, 18(1):266.
Options
Outlines

/

〈 〉